A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 39/02 (2006.01) A61K 39/04 (2006.01) A61K 39/106 (2006.01) C07K 14/23 (2006.01) C12N 15/00 (2006.01) C12N 15/74 (2006.01) C12P 21/06 (2006.01)
Patent
CA 2317806
This invention relates to an over-expressing homologous antigen vaccine, a method of producing the same, and use of the vaccine for prophylaxis or treatment of vertebrates at risk of or suffering form disease caused by a pathogenic micro-organism. The vaccine is an attenuated or avirulent pathogenic micro-organism that over-expresses at least one homologous antigen encoded by at least one gene derived form the pathogenic micro-organism, and may also express a heterologous antigen.
Cette invention concerne un vaccin contenant un alloantigène surexprimé, un procédé de préparation de ce vaccin et l'utilisation de ce dernier dans la prophylaxie ou le traitement de vertébrés qui présentent le risque de souffrir d'une maladie provoquée par un micro-organisme pathogène ou qui souffrent déjà d'une telle maladie. Le vaccin est un micro-organisme pathogène atténué ou avirulent qui surexprime au moins un alloantigène codé par au moins un gène provenant du micro-organisme pathogène, et qui peut également exprimer un antigène hétérologue.
Boyle Stephen M.
Corbeil Lynette
Cravero Silvio
Schurig Gerhardt G.
Srirnaganathan Nammalwar
Regents Of The University Of California
Sim & Mcburney
Virginia Tech Intellectual Properties Inc.
LandOfFree
An over-expressing homologous antigen vaccine and a method... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with An over-expressing homologous antigen vaccine and a method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An over-expressing homologous antigen vaccine and a method... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1694719